Navigation Links
ImaginAb, Inc. Awarded $2.3 Million from the National Cancer Institute
Date:10/31/2011

LOS ANGELES, Oct. 31, 2011 /PRNewswire/ -- ImaginAb, Inc. is pleased to announce that it has been awarded a total of $2.3 million in funding from the National Cancer Institute's (NCI) Small Business Innovation Research (SBIR) program to help further develop diagnostic imaging agents for Positron Emission Tomography (PET). Over the past 20 years, PET has evolved into a powerful and highly valued tool for the clinical management of cancer but many important areas of oncology still lack effective diagnostic and staging tools – particularly pancreatic and prostate cancer. It is estimated that over 70,000 people in the United States alone die of pancreatic and prostate cancer annually. ImaginAb's Head of Pre-Clinical Development, Dr. David Ho, will be the Principal Investigator in close collaboration with Dr. David Colcher at the City of Hope (Duarte, CA). ImaginAb will use this funding over the next two years to further accelerate its clinical program.

"The NCI SBIR program has become a very important source of financing for early-stage oncology companies, particularly considering the lack of risk capital available and changes in the early stage venture capital landscape over the past few years," noted Dr. Christian Behrenbruch, CEO of ImaginAb. "These funds from the NCI will be invested alongside ImaginAb resources to help drive our prostate and pancreatic oncology program ahead even more aggressively. The NCI has been a true partner in helping move our technology forward and have provided not only funding, but also access to clinical expertise and relationships with potential investors and pharma."

"For a company the size of ImaginAb, the NCI SBIR program is an invaluable source of funds that will greatly help with moving our lead products closer to commercialization," commented Jenny Keppler, ImaginAb's President and Chief Operating Officer.  "The highly competitive and peer-reviewed nature of NCI funding ensures that the most promising research is given an opportunity for development and commercialization."

About ImaginAb, Inc.

Founded in 2007 by UCLA Faculty (Drs. Robert Reiter, Anna Wu and Christian Behrenbruch), ImaginAb, Inc. is a biotechnology company specializing in the development of engineered antibody fragments for diagnostic imaging and novel therapeutic applications. The company has a significant pipeline of clinical products in development oriented towards unmet needs in cancer and immunology. ImaginAb is also developing a range of pre-clinical (animal imaging) reagents for use with microPET, microSPECT and optical imaging systems, and partners on a selective basis with biopharmaceutical companies with an interest in developing companion imaging agents for therapeutic antibody products. For more information about ImaginAb, visit www.imaginab.com.

Available Topic Expert(s): For information on the listed expert(s), click appropriate link.

Anna Wu

https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=91513


'/>"/>
SOURCE ImaginAb, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. ImaginAb, Inc. Announces Availability of Custom Protein Radiolabeling Services for Molecular Imaging
2. ImaginAb, Inc. and Dainippon Seiki (DNS) Co., Ltd. Conclude Technology Development Agreement for Automated Chemistry Systems
3. ImaginAb, Inc. and Eurogentec S.A. Collaborate to Produce Antibody Fragments in Pichia
4. ImaginAb, Inc. and GlaxoSmithKline Establish Collaboration
5. Bacterin Awarded Approved Vendor Status for American Medical Concepts Network of Hospitals in the Northwest U.S.
6. Darah Medical Awarded GSA Schedule, Launches Online Store
7. SensoScientific Awarded Contract by Premier Health Care Alliance for its Breakthrough WI-FI Temperature Monitoring System
8. MAQUET Cardiovascular Awarded Three-Year Contract From Premier Healthcare Alliance for Intra-Aortic Balloon Pumps
9. Argos Therapeutics Late Scientific Co-founder Ralph Steinman, M.D., Awarded Nobel Prize in Medicine for Discovery of Dendritic Cells as Critical Sentinels of Immune System
10. STELARA® Awarded 2011 Prix Galien USA in Best Biotechnology Product Category
11. University of Michigan Pediatric Device Inventors Awarded Funds to Design Child-Specific Medical Devices
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... 27, 2017  Twist Bioscience, a company accelerating science ... that it raised an additional $33 million. To date, ... "It is an exciting time to ... and continue to deliver industry-leading gene volume to our ... Emily M. Leproust, Ph.D., CEO of Twist Bioscience. "We ...
(Date:3/27/2017)... , March 27, 2017  PhaseRx, Inc. (NASDAQ: ... life-threatening inherited liver diseases in children, today reported ... year ended December 31, 2016 and provided an ... "PhaseRx continued to make progress during the fourth ... results from our non-human primate safety study, and with ...
(Date:3/27/2017)... , March 27, 2017 Invivotek, LLC, a ... in vivo pharmacology contract research organization (CRO), ... to its newly expanded preclinical research facility in ... provides a cleaner, renewable energy source to reduce costs ... Completion of the Genesis Solar Farm follows Invivotek,s recent ...
Breaking Medicine Technology:
(Date:3/27/2017)... London UK (PRWEB) , ... March 27, 2017 ... ... agility and ability to gain site attention and engagement over the household brands ... educational webinar will discuss how partnering with the right outsourcing payments ...
(Date:3/27/2017)... (PRWEB) , ... March 27, 2017 , ... A study ... Buckingham MD, and his colleague, Sudeep Roy, MD, was recently published in the ... Electrocautery Efficacy in Rhytidectomy” details Drs. Buckingham and Roy’s study on the use of ...
(Date:3/27/2017)... ... March 27, 2017 , ... Buzzies parent company, The ... for Rent the Runway Foundation and UBS’ Project Entrepreneur. Mayo will present her pitch ... 8. , Project Entrepreneur’s second annual venture competition ignites bold ideas by providing ...
(Date:3/27/2017)... Niles, IL (PRWEB) , ... March 27, 2017 ... ... testing systems, recently received the CE Certificate of Conformity for the Smart System® ... meet or exceed the highest industry standards and specifications such as ANSI, ISO ...
(Date:3/27/2017)... ... March 27, 2017 , ... American Veterinarian™, the leading ... veterinary medicine, announces the launch of Veterinarian’s Money Digest™, a business and financial ... edition of American Veterinarian™. , “We look forward to launching Veterinarian’s ...
Breaking Medicine News(10 mins):